Short Communication - (2015) Volume 3, Issue 1
Serum Soluble CD25 and CD30 Levels as a Biomarker in Adult T-Cell Leukemia/Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- Shigeki Takemoto1,2*
- 1Department of International Cooperation, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
- 2Clinical Laboratory, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
*Corresponding Author:
Shigeki Takemoto,
M.D., Ph.D., Chief of Clinical laboratory, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Kumamoto 860-0008, Japan, Tel: +81-(0)96-353-6501, Fax: +81-(0)96-325-2519
Email:
